Conference

“Evidence in a Time of Crisis”

October 25-27, 2021

Virtual

PROGRAM,
click here for most recent draft

sessions highlights:

  • Closing the gaps to timely patient access
  • CAR-T- RWE generations and impact on HTA
  • Patient Support Programs (PSP) and Rare Disease: Utilization of RWE in Strategy
  • New Methods in Lifecycle HTA to Manage Uncertainty
  • Whose perspective, modeling in a time of crisis– What has the pandemic taught us?
  • Day 1 Keynote – Dr. Gerald Batist and MJ DeCoteau, Executive Director of Rethink Breast Cancer
  • Day 2 Keynote – Dr. Lorne.Tyrrell – Vaccine selection:  decision making in real-time during a pandemic.   Biography, Dr. Tyrrell

ABSTRACTS

12 of the top ranked abstracts will be presented on days 1 & 2

All accepted abstract will be published post conference in The Journal of Population Therapeutics & Clinical Pharmacology www.jptcp.com

Poster Presentations

Posters presentations from our 2020 conference can be accessed via our online poster gallery here

a similar gallery will be created for the 2021 abstracts.

PARTNERS

CAPT-ACTP gratefully acknowledges our 2021 partners:

LEVEL 1
AstraZeneca Canada Inc
Biogen
Gilead Sciences Canada Inc.
IHE Institute of Health Economics
Innomar Strategies
IQVIA

LEVEL 2
Merck Canada

LEVEL 3

Amgen Canada Inc.
J.L. Glennie Consulting Inc.
PDCI


LEVEL 4
Astellas
HOPE Research Centre
Leo Pharma

 

 


Learn more about CAPT-ACTP!

CAPT ACTP Brochure